AMD Management During the COVID‐19 Pandemic

Colantuono, Donato; Mière, Alexandra; Semoun, Oudy; Amoroso, Francesca

doi:10.1111/aos.14469

Cited by 12 publications

(21 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In term of in-person visits, the number signi cantly increased for the uveitis division given the reliance on slit lamp evaluation for cell and are. 20 Correspondingly, there was a signi cant increase in the numbers of ICD-10 codes for all anatomic locations of undifferentiated uveitis and scleritis. Concurrently, uveitic glaucoma ICD-10 codes signi cantly increased in the weeks after COVID-19.…”

Section: Discussionmentioning

confidence: 98%

“…This group included patients on immunosuppressive medications prescribed to treat ocular in ammation, illustrating the need to safely continue these medications, in-person evaluations, and lab draws to in the time of COVID-19. 20,37 Interestingly, all types of herpetic eye diseases increased in frequency signi cantly in the 6 weeks after COVID-19. Herpetic disease has been associated with depression as a trigger for reactivation, which has also been noted to increase during COVID 19.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Changes in Patient Visits and Diagnoses seen in an Academic Ophthalmology Department during the COVID-19 pandemic

Berkenstock¹,

Liberman

McDonnell

et al. 2020

Preprint

View full text Add to dashboard Cite

BACKGROUND: To minimize the risk of viral transmission, ophthalmology practices limited face to face encounters to only patients with urgent and emergent ophthalmic conditions, in the weeks after the start of the COVID-19 epidemic in the United States. The impact of this is unknown. METHODS: We did a retrospective analysis of the change in the frequency of ICD-10 code use and patient volumes in the six weeks before and after the changes in clinical practice associated with COVID-19.RESULTS: The total number of encounters decreased four-fold after the implementation of clinic changes associated with COVID-19. The low vision, pediatric ophthalmology, general ophthalmology, and cornea divisions had the largest decrease of in-person visits. Conversely, telemedicine visits increased sixty-fold. The number of diagnostic codes associated with ocular malignancies, most ocular inflammatory disorders, and retinal conditions requiring intravitreal injections increased. ICD-10 codes associated with ocular screening exams for systemic disorders decreased during the weeks post COVID-19. CONCLUSION: Ophthalmology practices need to be prepared to experience changes in practice patterns, implementation of telemedicine, and decreased patient volumes during a pandemic. Knowing the changes specific to each subspecialty clinic is vital to redistribute available resources correctly.

show abstract

Section: Discussionmentioning

confidence: 98%

Section: Discussionmentioning

confidence: 99%

Changes in Patient Visits and Diagnoses seen in an Academic Ophthalmology Department during the COVID-19 pandemic

Berkenstock¹,

Liberman

McDonnell

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…Retinal conditions at high risk for complications, such as inactive wet macular degeneration, and conditions requiring continuation of intravitreal injections, such as diabetic macular edema, continued to be seen frequently in alignment with recommendations for continued treatment during COVID-19. 19,21,26 One of the highest risk groups for complications related to COVID-19 infection are those over 65 years-old or with pre-existing health conditions, which describes the demographics of many patients receiving intravitreal injections. 19,26,35 Patients and providers needed to weigh the risk of possible COVID-19 exposure with disease progression or the development of additional ocular complications with the postponement of anti-vascular endothelial growth factor (anti-VEGF) injections and possible disease progression.…”

Section: Discussionmentioning

confidence: 99%

“…19,26,35 Patients and providers needed to weigh the risk of possible COVID-19 exposure with disease progression or the development of additional ocular complications with the postponement of anti-vascular endothelial growth factor (anti-VEGF) injections and possible disease progression. 19 Interestingly, the codes for neovascular glaucoma (NVG) signi cantly increased in the six weeks post-COVID. Thus, a further study is needed to assess the relationship between the increase in NVG ICD-10 codes and the postponement of anti-VEGF injections during the pandemic.…”

Section: Discussionmentioning

confidence: 99%

“…19,21,26 One of the highest risk groups for complications related to COVID-19 infection are those over 65 years-old or with pre-existing health conditions, which describes the demographics of many patients receiving intravitreal injections. 19,26,35 Patients and providers needed to weigh the risk of possible COVID-19 exposure with disease progression or the development of additional ocular complications with the postponement of anti-vascular endothelial growth factor (anti-VEGF) injections and possible disease progression. 19 Interestingly, the codes for neovascular glaucoma (NVG) signi cantly increased in the six weeks post-COVID.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Changes in Patient Visits and Diagnoses seen in an Academic Ophthalmology Department during the COVID-19 pandemic

Berkenstock¹,

Liberman²,

McDonnell³

et al. 2020

Preprint

View full text Add to dashboard Cite

BACKGROUND: To minimize the risk of viral transmission, ophthalmology practices limited face to face encounters to only patients with urgent and emergent ophthalmic conditions, in the weeks after the start of the COVID-19 epidemic in the United States. The impact of this is unknown. METHODS: We did a retrospective analysis of the change in the frequency of ICD-10 code use and patient volumes in the six weeks before and after the changes in clinical practice associated with COVID-19.RESULTS: The total number of encounters decreased four-fold after the implementation of clinic changes associated with COVID-19. The low vision, pediatric ophthalmology, general ophthalmology, and cornea divisions had the largest total decrease of in-person visits. Conversely, the number of telemedicine visits increased sixty-fold. The number of diagnostic codes associated with ocular malignancies, most ocular inflammatory disorders, and retinal conditions requiring intravitreal injections increased. ICD-10 codes associated with ocular screening exams for systemic disorders decreased during the weeks post COVID-19. CONCLUSION: Ophthalmology practices need to be prepared to experience changes in practice patterns, implementation of telemedicine, and decreased patient volumes during a pandemic. Knowing the changes specific to each subspecialty clinic is vital to redistribute available resources correctly.

show abstract

Drop in well-being of ARMD patients under treatment with anti-VEGF injections during the COVID-19 pandemic

et al. 2022

View full text Add to dashboard Cite

for the impact of the pandemic on their ongoing ARMD treatment. Results There was a significant drop in mental well-being during the pandemic that paralleled the self-reported impact of the pandemic on ARMD treatment. Patients who reported a higher impact of COVID-19 on their treatment had experienced a higher drop in mental wellbeing compared to those who hadn't, with female gender being an additional risk factor. Objective measurements of visual acuity did not factor in the drop of sense of well-being. Conclusions The high initial level of uncertainty regarding ARMD patients' long-term course was further exacerbated when exposed to additional uncertainties during the pandemic regarding their standard of care. Planning ahead for continuation of services and close contact with patients during similar health emergencies is of paramount importance.

show abstract

AMD Management During the COVID‐19 Pandemic

Cited by 12 publications

References 3 publications

Changes in Patient Visits and Diagnoses seen in an Academic Ophthalmology Department during the COVID-19 pandemic

Changes in Patient Visits and Diagnoses seen in an Academic Ophthalmology Department during the COVID-19 pandemic

Changes in Patient Visits and Diagnoses seen in an Academic Ophthalmology Department during the COVID-19 pandemic

Drop in well-being of ARMD patients under treatment with anti-VEGF injections during the COVID-19 pandemic

Contact Info

Product

Resources

About